FDA Meeting Scheduled Could Accelerate Approval Path for uniQure’s Huntington’s Disease Gene Therapy
Market Chameleon (Fri, 9-Jan 7:28 AM)
FDA Feedback Challenges QURE’s Huntington’s Therapy Timeline—Regulatory Path Uncertain After Phase I/II Data
Market Chameleon (Thu, 4-Dec 9:54 AM)
FDA Feedback Raises Bar for uniQure’s AMT-130 Huntington’s Therapy—Company to Seek Rapid Follow-up Meeting
Market Chameleon (Thu, 4-Dec 7:28 AM)
